Cryptococcal meningitis in non-HIV-infected patients in a Chinese tertiary care hospital, 1997–2007

References

• Mitchell TG, Perfect JR. Cryptococcosis in the era of AIDS –100 years after the discovery of Cryptococcus neoformans. Clin Microbiol Rev 1995; 8: 515–548.
   PubMed Web of Science ®Google Scholar
• Mirza SA, Phelan M, Rimland D, . The changing epidemiology of cryptococcosis: an update from population-based active surveillance in 2 large metropolitan areas, 1992–2000. Clin Infect Dis 2003; 36: 789–794.
   PubMed Web of Science ®Google Scholar
• Dromer F, Mathulin-Pelissier S, Fontanet A, . Epidemiology of HIV-associated cryptococcosis in France (1985–2001): comparison of the pre- and post-HAART eras. AIDS 2004; 18: 556–562.
   Google Scholar
• Antinori S, Ridolfo A, Fasan M, . AIDS-associated cryptococcosis: a comparison of epidemiology, clinical features and outcome in the pre- and post-HAART eras. Experience of a single centre in Italy. HIV Med 2009; 10: 6–11.
   PubMed Web of Science ®Google Scholar
• Zonios DI, Falloon J, Huang C, Chaitt D, Bennett JE. Cryptococcosis and idiopathic CD4 lymphocytopenia. Medicine (Baltimore) 2007; 86: 78–92.
   PubMedGoogle Scholar
• Pukkila-Worley R, Mylonakis E. Epidemiology and management of cryptococcal meningitis: developments and challenges. Expert Opin Pharmacother 2008; 9: 551–560.
   PubMed Web of Science ®Google Scholar
• Singh N, Dromer F, Perfect JR, Lortholary O. Cryptococcosis in solid organ transplant recipients: current state of the science. Clin Infect Dis 2008; 47: 1321–1327.
   PubMed Web of Science ®Google Scholar
• Pappas PG, Perfect JR, Cloud GA, . Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy. Clin Infect Dis 2001; 33: 690–699.
   PubMed Web of Science ®Google Scholar
• Bennett JE, Dismukes WE, Duma RJ, . A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptococcal meningitis. N Engl J Med 1979; 301: 126–131.
   PubMed Web of Science ®Google Scholar
• Dismukes WE, Cloud G, Gallis HA, . Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks. N Engl J Med 1987; 317: 334–341.
   PubMed Web of Science ®Google Scholar
• Dromer F, Mathoulin S, Dupont B, Brugiere O, Letenneur L. Comparison of the efficacy of amphotericin B and fluconazole in the treatment of cryptococcosis in human immunodeficiency virus-negative patients: retrospective analysis of 83 cases. French Cryptococcosis Study Group. Clin Infect Dis 1996; 22: S154–160.
   PubMedGoogle Scholar
• Centers for Disease Control. Unexplained CD4+ T-lymphocyte depletion in persons without evident HIV infection. United States. Morb Mortal Wkly Rep 1992; 41: 541–545.
   PubMedGoogle Scholar
• Jiang W, Kang L, Lu HZ, . Normal values for CD4 and CD8 lymphocyte subsets in healthy Chinese adults from Shanghai. Clin Diagn Lab Immunol 2004; 11: 811–813.
   PubMedGoogle Scholar
• Chayakulkeeree M, Perfect JR. Cryptococcosis. Infect Dis Clin N Am 2006; 20: 507–544.
   PubMed Web of Science ®Google Scholar
• Segal BH, Herbrecht R, Stevens DA, . Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria. Clin Infect Dis 2008; 47: 674–683.
   PubMed Web of Science ®Google Scholar
• Diamond RD, Bennett JE. Prognostic factors in cryptococcal meningitis. A study in 111 cases. Ann Intern Med 1974; 80: 176–181.
   PubMed Web of Science ®Google Scholar
• Dromer F, Mathoulin S, Dupont B, Laporte A. Epidemiology of cryptococcosis in France: a 9-year survey (1985–1993). French Cryptococcosis Study Group. Clin Infect Dis 1996; 23: 82–90.
   PubMed Web of Science ®Google Scholar
• Dromer F, Mathoulin-Pélissier S, Launay O, Lortholary O. Determinants of disease presentation and outcome during cryptococcosis: the CryptoA/D study. PLos Med 2007; 4: e21.
   PubMed Web of Science ®Google Scholar
• Kiertiburanakul S, Wirojtananugoon S, Pracharktam R, Sungkanuparph S. Cryptococcosis in human immunodeficiency virus-negative patients. Int J Infect Dis 2006; 10: 72–78.
   PubMed Web of Science ®Google Scholar
• Lui G, Lee N, Ip M, . Cryptococcosis in apparently immunocompetent patients. QJM 2006; 99: 143–151.
   PubMed Web of Science ®Google Scholar
• Lu CH, Chang HW, Chuang YC. The prognostic factors of cryptococcal meningitis in HIV-negative patients. J Hospital Infect 1999; 42: 313–320.
   PubMed Web of Science ®Google Scholar
• Shih CC, Chen YC, Chang SC, Luh KT, Hsieh WC. Cryptococcal meningitis in non-HIV-infected patients. QJM 2000; 93: 245–251.
   Web of Science ®Google Scholar
• Wu MH, Xu ZY, Weng XH, . A clinical analysis of 74 cases of cryptococcosis. Acta Academiae Med Shanghai 1987; 14: 457–459.
   Google Scholar
• Yao Z, Liao W, Chen R. Management of cryptococcosis in non- HIV-related patients. Med Mycol 2005; 43: 245–251.
   PubMed Web of Science ®Google Scholar
• Tjia TL, Yeow YK, Tan CB. Cryptococcal meningitis. J Neurol Neurosurg Psychiatry 1985; 48: 853–858.
   PubMed Web of Science ®Google Scholar
• Richardson PM, Mohandas A, Arumugasamy N. Cerebral cryptococcosis in Malaysia. J Neurol Neurosurg Psychiatry 1976; 39: 330–337.
   PubMed Web of Science ®Google Scholar
• Wu G, Vilchez RA, Eidelman B, . Cryptococcal meningitis: an analysis among 5521 consecutive organ transplant recipients. Transpl Infect Dis 2002; 4: 183–188.
   PubMedGoogle Scholar
• Ecevit IZ, Clancy CJ, Schmalfuss IM, Nguyen MH. The poor prognosis of central nervous system cryptococcosis among nonimmunosuppressed patients: a call for better disease recognition and evaluation of adjuncts to antifungal therapy. Clin Infect Dis 2006; 42: 1443–1447.
   PubMed Web of Science ®Google Scholar
• White M, Cirrincione C, Blevins A, . Cryptococcal meningitis: outcome in patients with AIDS and patients with neoplastic disease. J Infect Dis 1992; 165: 960–963.
   PubMed Web of Science ®Google Scholar
• Saag MS, Graybill RJ, Larsen RA, . Infectious Diseases Society of America. Practice guidelines for the management of cryptococcal disease. Clin Infect Dis 2000; 30: 710–718.
   PubMed Web of Science ®Google Scholar
• Bicanic T, Harrison T, Niepieklo A, Dyakopu N, Meintjes G. Symptomatic relapse of HIV-associated cryptococcal meningitis after initial fluconazole monotherapy: the role of fluconazole resistance and immune reconstitution. Clin Infect Dis 2006; 43: 1069–1073.
   PubMed Web of Science ®Google Scholar
• Husain C, Wagener MM, Singh N. Cryptococcus neoformans infection in organ transplant recipients: variables influencing clinical characteristics and outcome. Emerg Infect Dis 2001; 7: 375–381.
   PubMed Web of Science ®Google Scholar